ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves First Generic Version of Sabril
January 17, 2019The U.S. Food and Drug Administration (FDA) has approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures..... -
FDA tackles drug competition to improve patient access
June 29, 2017Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives.
Pharma Sources Insight January 2025
